SIRT3, via the activation of FOXO3, leads to induction clustering of p62—also a common component of Lewy bodies in Parkinson’s disease [33]—on ubiquitinated mitochondrial substrates, alleviating AD-associated toxicity [89]. This evidence concerns the gene SIRT3 and Parkinson disease.